MAKNA-HCTM CANCER INSTITUTE

The MAKNA-HCTM cancer institute, established in 1999 in collaboration with Hospital Canselor Tuanku Muhriz UKM (HCTM), provides comprehensive and state-of-the-art facilities to cancer patients of all financial backgrounds. The cancer institute comprises an oncology ward, radiotherapy services centre and a bone marrow transplant ward.


In 2020,

  • This is the 1st item
  • This is the 2nd item
  • Ward capacity were reduced by 50% and operated as usual during the pandemic.
  • BMT ward was on standby for COVID-19 ward.

TENGKU AMPUAN AFZAN
ONCOLOGY WARD

Total Patient Admitted

RADIOTHERAPY

2020 : 58
2021 : 8

BRACHYTHERAPY

2020 : 14
2021 : 7

PALLIATIVE

2020 : 49
2021 : 7

CHEMOTHERAPY

2020 : 163
2021 : 19

SYMPTOMATIC

2020 : 550
2021 : 71

OTHERS

2020 : 107
2021 : 21

BONE MARROW TRANSPLANT (BMT)
WARD

The BMT ward continue to provide in-patient services to cancer patients.

No. of patient admitted

    • 202091%
    • 202117%

    Stem cell harvesting

      • 202024%
      • 20214%

      Peripheral blood stem cell transplant

        • 20209%
        • 20216%